AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

RecruitingPhase 4Ages 12 Years - anyAllWashington University School of Medicine
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers. The investigators will roll out these resources in stages across clinics. The study will measure how well the program helps clinicians prescribe SMART therapy and whether it reduces asthma exacerbations in patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
The study population can be viewed from the cluster (clinic), clinician, staff, or patient level. At the cluster (clinic) level: To be eligible to participate in this study, a cluster (clinic) must meet all the following criteria: (1) Clinics within participating health systems (Affinia Healthcare and Family Care Health Centers) will be considered eligible if they provided care to โ‰ฅ100 patients aged โ‰ฅ12 years with asthma (ICD-10-CM: J45.xx) during the calendar year preceding implementation (2024). At the clinician level: Clinicians will be considered eligible if they: 1. are physicians, nurse practitioners, or physician assistants; 2. are actively employed at a participating clinic during the implementation period; and 3. provided care to โ‰ฅ10 patients aged โ‰ฅ12 years with asthma (ICD-10-CM: J45.xx) during the 12 months preceding implementation. At the staff level: Staff will be considered eligible if they: 1. are actively employed at a participating clinic during the implementation period; and 2. directly support clinical care delivery for patients aged โ‰ฅ12 years with asthma. At the patient level: Patients will be considered eligible if they: 1. are aged โ‰ฅ12 years; 2. received care at a participating clinic during the implementation period; and (3) meet the study-defined definition of moderate-to-severe asthma based on diagnosis codes, medication use, and/or exacerbation history as defined in the study protocol.
๐Ÿ’Š

What it tests

  • Implementation bundle
๐Ÿ“

Where

7 sites
Affinia healthcare, 2220 Lemp Ave
St Louis, United States
Affinia healthcare, 1717 Biddle Street
St Louis, United States
Affinia healthcare, 4414 North Florissant Avenue
St Louis, United States
Family Care Heath Center, 4352 Manchester Ave
St Louis, United States
Washington University in St. Louis School of Medicine
St Louis, United States
Family Care Heath Center, 401 Holly Hills Ave
St Louis, United States
Affinia healthcare, 3396 Pershall Road,
St Louis, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy